SecBot SecBot

LH

LABCORP HOLDINGS INC.
NYSE· Services-Medical Laboratories· CIK 0000920148 Healthcare & Medical Devices
$370.48 −1.84 (−0.49%)
Nov 13 4:00 PM ET · prev $372.32
Market cap
$30.2B
Large cap
Consensus
Buy
78% Buy or better · 27 analysts
Median target
$395.50
+7% · range $347.00–420.00
1 year
+41.7%
from $261.37 · Nov 17
30 days
+16.2%
from $318.83
52-week range
$250.39–372.32
−0% from high · low Jan 12
Avg volume 20D
783.2K
shares / day
Short interest
2.54M
≈3.1% of shares · −0.5%
Days to cover
3.0
at average volume
Insider net
−$6.9M
0 buyers · 9 sellers · since Mar 26
New fund stakes
2
Q3 2026 13F · 0 exits
Filing reports
27
analyzed by SecBot
SecBot read BULLISH 17 reports · 90 days
Balance 0 bearish · 2 bullish · 15 neutral oldest → newest, height = score
Avg score ·High conf. 16/17

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    9 insiders sold $6.9M.

  • InstitutionsBULLISH

    Q3 2026: 42 added (2 new), 26 trimmed or exited. Largest new: Hrt Financial $21.8M, Jump Financial $17.1M.

  • AnalystsBULLISH

    21 of 27 rate it Buy or better. Median target $395.50 (+7%).

  • Short sellersSTEADY

    Short interest −0.5% to 2.54M shares. 3.0 days to cover, ≈3.1% of shares.

  • TrendUPTREND

    12% above its 50-day average. New closing high $372.32 on Nov 12.

Who's buying

13F· Q3 2026
2
new positions
0
exits
$38.9M
in new stakes
FundMoveSharesValue
FMR LLCADD3,689,552$1.1B
JPMORGAN CHASE & COTRIM839,220$259.2M
AMERICAN CENTURY COMPANIES INCTRIM614,139$189.2M
Diamond Hill Capital Management, LLC (Investment Advisor)TRIM449,901$138.6M
AmundiTRIM409,595$126.2M
UBS Group AGTRIM335,819$103.5M
FRANKLIN TEMPLETON INCDOUBLED261,323$96.1M
CITIGROUP INCADD174,161$53.7M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

27 analysts
Buy 78% rate it Buy or better
Strong Buy9Buy12Hold6Sell0Strong Sell0
12-month targets · 16 analysts

Price is inside the target range. Median implies +7%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Oct 29, 2026UBS
MAINTAIN
MAINTAINBuy
Oct 29, 2026Barclays
MAINTAIN
MAINTAINEqual-Weight
Oct 29, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Oct 29, 2026Baird
MAINTAIN
MAINTAINOutperform
Sep 21, 2026Truist Securities
MAINTAIN
MAINTAINBuy
Sep 11, 2026UBS
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$6.9M
sold · 9 insiders
DateInsiderTypeValue
Nov 10, 2026
Caveney Brian J
EVP, Pres of BLS, CMO & CSO
Nov 10, 2026
SELL$744.1K
Nov 3, 2026
Vaughn Bryan T
EVP and President, Diagnostics
Nov 3, 2026
SELL$108.2K
Nov 2, 2026
Oyegunwa Akinbolade
EVP, CIO & CTO
Nov 2, 2026
TAX W/H$42.0K
Nov 2, 2026
Vaughn Bryan T
EVP and President, Diagnostics
Nov 2, 2026
TAX W/H$69.0K
Nov 1, 2026
Oyegunwa Akinbolade
EVP, CIO & CTO
Nov 1, 2026
EXERCISE370 sh
Nov 1, 2026
Vaughn Bryan T
EVP and President, Diagnostics
Nov 1, 2026
EXERCISE500 sh
Oct 30, 2026
Parham Richelle P
Director
Oct 30, 2026
SELL$389.4K
Sep 1, 2026
Oyegunwa Akinbolade
EVP, CIO & CTO
Sep 1, 2026
AWARD750 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

Short side

FINRA· Oct 30, 2026
2,544,414
shares short
-0.5%
vs prior settlement
3.0
days to cover
≈3.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Two Labcorp executives sold shares totaling $852K in the past week. EVP Caveney sold $744K in an open-market sale…
CLUSTER · Impact 2/10
Nov 10, 2026 SEC
Brian J. Caveney, an officer of Labcorp Holdings Inc., filed a Form 144 notice of intent to sell 2,000 shares of…
144 · Impact 2/10
Nov 10, 2026 Insider
Caveney Brian J sold 2,000 shares
EVP, Pres of BLS, CMO & CSO @ $372.04 ($744.1K)
Nov 5, 2026 SEC
Two insiders at Labcorp sold shares in the week following strong Q3 earnings and raised guidance. Director Parham sold…
CLUSTER · Impact 2/10
Nov 4, 2026 Other
Labcorp to Speak at the UBS Global Healthcare Conference
BURLINGTON, N.C., Nov. 4, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and
Nov 3, 2026 Insider
Vaughn Bryan T sold 306 shares
EVP and President, Diagnostics @ $353.70 ($108.2K)
Nov 2, 2026 Insider
Oyegunwa Akinbolade surrendered for taxes 118 shares
EVP, CIO & CTO @ $355.59 ($42.0K)
Oct 21, 2026 Press
Labcorp declared a quarterly cash dividend of $0.72 per share, maintaining its regular payout. This is a routine…
Impact 2/10
Congressional trades
LH trades disclosed by members of Congress, with disclosure delay.
3 members · 5 buys / 5 sells
DateMemberType AmountDisclosed
Oct 7, 2026 Ro KhannaDHouse Spouse account · Laboratory Corp of America Holdings SELL $1K–$15K Nov 5, 2026 +29d
Sep 4, 2026 Ro KhannaDHouse Spouse account · Laboratory Corp of America Holdings BUY $1K–$15K Oct 7, 2026 +33d
Aug 25, 2026 April McClain DelaneyDHouse Child account · Laboratory Corp of America Holdings SELL $100K–$250K Sep 9, 2026 +15d
Aug 7, 2026 April McClain DelaneyDHouse Child account · Laboratory Corp of America Holdings SELL $1K–$15K Sep 9, 2026 +33d
Aug 6, 2026 April McClain DelaneyDHouse Child account · Laboratory Corp of America Holdings SELL $1K–$15K Sep 9, 2026 +34d
Aug 5, 2026 April McClain DelaneyDHouse Child account · Laboratory Corp of America Holdings SELL $1K–$15K Sep 9, 2026 +35d
May 15, 2026 Ro KhannaDHouse Spouse account · Laboratory Corp of America Holdings BUY $1K–$15K Jun 9, 2026 +25d
Feb 19, 2026 Anthony WiedRHouse Joint account · Laboratory Corp of America Holdings BUY $15K–$50K Mar 9, 2026 +18d
Feb 11, 2026 April McClain DelaneyDHouse Child account · Laboratory Corp of America Holdings BUY $1K–$15K Mar 10, 2026 +27d
Feb 4, 2026 April McClain DelaneyDHouse Child account · Laboratory Corp of America Holdings BUY $1K–$15K Mar 10, 2026 +34d

SecBot reports

27 filings · 2 press releases · 3 bullish · 1 bearish · 23 neutral
All LH filing & press-release reports (29)